.png?w=3840)
Germany
,02.May, 2022
Exyte GmbH changes its board structure in line with accelerated growth path, the “Pathway to Ten”
In order to align the leadership structure of Exyte with its strategic growth plan 'Pathway to Ten' (Exyte’s plan to reach annual sales of €10 bn by 2027), the Executive Board together with the Supervisory Board of Exyte have decided to strengthen the three strategic units of Exyte, Advanced Technology Facilities (ATF), Biopharma and Life Sciences (BLS), and Data Centers (DTC) by extending the Executive Board of Exyte with respective Board representations of these segments. As a consequence, the role of the Chief Operating Officer will be abolished while three new Board positions are created. The future Board of Exyte will comprise five members.
- Effective May 01, 2022 Exyte is extending its Board by elevating business responsibility to the Board Level
- Strong business growth continues with focus on the 3 strategic pillars
- The Supervisory Board together with Roberto Penno have agreed that he will leave Exyte
Dr. Wolfgang Büchele, Chief Executive Officer of Exyte will, in addition to his current role, assume responsibility for the Segments Advanced Technology Facilities (ATF) and Biopharma and Life Sciences (BLS) at the Board level. He will also be responsible for the Region Asia, which comprises the Regional Areas Northeast Asia (NEA) and Southeast Asia (SEA). In addition, the Business Area Technology and Services (T&S), the fourth strategic unit of Exyte, will report to him.
Peter Schönhofer, Chief Financial Officer of Exyte, will, in addition to his current role, assume the responsibility for the Segment Data Centers (DTC) at the Board level. He will also be responsible for the Regions Europe, which comprise the Regional Areas Continental Europe (COE) and Northern Europe & Israel (NEI), and the US (Regional Area USA).
Following this decision on a new extended Board structure, the additional Board Members will be appointed in the course of 2022 and 2023 to assume the respective additional responsibilities from Dr. Wolfgang Büchele and Peter Schönhofer.
“With our new Board structure, we are laying the foundation for future accelerated growth in line with our successful focus on our 4 strategic units, driven by very strong and sustainable secular trends,” says Georg Stumpf, Chairman of the Supervisory Board of Exyte GmbH.
The Supervisory Board and Roberto Penno have agreed that he will be released from his duties as Chief Operating Officer of Exyte to pursue other opportunities outside of the company. “I would like to thank Roberto Penno for his excellent contribution to the development of Exyte over the last five years,” says Georg Stumpf. “We wish Roberto Penno all the best for his future endeavors.”

Public Relations Manager
Samy Abdel Aal
For any further question or should you require additional information please feel free to contact:
Phone: +49 711 88044696
Mobil: +49 172 840 33 01
samy.abdelaal@exyte.net
Please understand that our press office can only answer questions from
journalists. Please refer to our general contact email for contacts on other
matters.
Loading….
ARE YOU LOOKING FOR :

Innovation and Expertise
/201203PHOBLSPharma7-1dark.jpg?w=3840)
People and Stories
.jpg?w=3840)
About us
ARE YOU LOOKING FOR :

References
